Esticast Logo
Get In Touch!

Veterinary Anti-infectives Market By Animal (Livestock, Companion animals), By Drug Class (Antimicrobial agents, Antiviral agents, Antifungal agents, Anti-parasitic agents), By Mode of Administration (Oral, Parenteral, Topical), By End-user (Veterinary Hospitals, Veterinary Clinics, Pharmacies), Industry Trends, Estimation & Forecast, 2018-2025

  • Published On: Sep, 2018
  • Category: Healthcare
  • Pages: 184
Veterinary Anti-infectives Market is expected to grow with a CAGR of 3.6% during the forecast period of 2018 to 2025.

Market Overview:

The medication used for animals to fight against the infectious properties of pathogenic organisms is termed as veterinary anti-infectives. The surging incidences of zoonoses that result into mild or life threatening infections, and increasing food-borne diseases are the major factors fuelling the growth of the veterinary anti-infectives market. The infected animals transform into a suitable host for the disease causing pathogens, which then passes on into the human food chain resulting in an hike in the death rate of humans. The necessity to reduce such a death rate has propelled the veterans to curb the infectious disease causing organisms in the animals itself, which in turn is escalating the demand for veterinary anti-infectives across the globe. According to the Center for Disease Control and Prevention, nearly 3 out of every 4 emerging infectious diseases in humans are spread through animals. In addition, the increasing number of companion animals being owned by the global populace is also catalyzing the growth of the very market. As per the data cited by the American Society for the Prevention of Cruelty to Animals, around 6.5 million companion animals enter U.S. animal shelters nationwide every year and approximately 3.2 million are adopted each year. The lack of awareness towards animal health is emerging out as a major factor that is hindering the market growth. However, the advent of new animal drugs is expected to provide lucrative opportunities to the market players during the upcoming years. For instance, Zoetis launched Clavamox Chewable (amoxicillin and clavulanate potassium tablets) that are used for treating urinary tract infections in cats and periodontal infections in dogs. In terms of region, North America is expected to dominate the market throughout the forecast period due to the surging adoption of animals, increasing awareness regarding animal health, and adoption of pet insurance policies. The report provides detailed qualitative and quantitative analysis of the veterinary anti-infectives market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely species, drug class, mode of administration, and end user in each of the major regions.

Veterinary Anti-infectives Market Segmentation

By Animal • Livestock • Companion animals By Drug Class  • Antimicrobial agents • Antiviral agents • Antifungal agents • Anti-parasitic agents • Others By Mode of Administration  • Oral • Parenteral • Topical By End-user  • Veterinary Hospitals • Veterinary Clinics • Pharmacies • Others By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Rest of Europe • Asia-Pacific o China o Japan o India o Rest of APAC • Rest of the World o Latin America o Middle East o Africa

CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources
1.2. RESEARCH SCOPE

CHAPTER 2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET KEY INSIGHTS
2.1. RESEARCH SUMMARY
2.2. VETERINARY ANTI-INFECTIVES PRODUCTION (MILLION UNITS), 2014 – 2025
2.2. VETERINARY ANTI-INFECTIVES CONSUMPTION (MILLION UNITS), 2014 – 2025
2.3. VETERINARY ANTI-INFECTIVES REVENUE (MILLION UNITS), 2014-2025
2.4. MARKET SHARE ANALYSIS
2.4.1 Estimated market share of top (8 – 10) market players
2.5. DEMAND ESTIMATION, FORECAST AND STRATEGIC ANALYSIS

CHAPTER 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET DYNAMICS AND VALUE CHAIN ANALYSIS
3.1. KEY MARKET DRIVERS
3.2. RESTRAINING FACTORS
3.3. PREVAILING AND EMERGING BUSINESS OPPORTUNITIES

CHAPTER 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET BY ANIMALS
4.1. SEGMENT OUTLINE AND MARKET SHARE BY ANIMALS
4.2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET REVENUE & PRODUCTION VOLUME BY ANIMALS, 2014-2025
4.3. Livestock
4.3.1. Market growth indicators
4.3.2. Market revenue & production volume, 2014 – 2025
4.4. Companion animals
4.4.1. Market growth indicators
4.4.2. Market revenue & production volume, 2014 – 2025

CHAPTER 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET BY DRUG CLASS
5.1. SEGMENT OUTLINE AND MARKET SHARE BY DRUG CLASS
5.2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET REVENUE & VOLUME BY DRUG CLASS, 2014-2025
5.3. Antimicrobial agents
5.3.1. Market growth indicators
5.3.2. Market revenue & production volume, 2014 – 2025
5.4. Antiviral agents
5.4.1. Market growth indicators
5.4.2. Market revenue & production volume, 2014 – 2025
5.5. Antifungal agents
5.5.1. Market growth indicators
5.5.2. Market revenue & production volume, 2014 – 2025
5.6. Anti-parasitic agents
5.6.1. Market growth indicators
5.6.2. Market revenue & production volume, 2014 – 2025
5.7. Others
5.7.1. Market growth indicators
5.7.2. Market revenue & production volume, 2014 – 2025

CHAPTER 6. GLOBAL VETERINARY ANTI-INFECTIVES MARKET BY MODE OF ADMINISTRATION
6.1. SEGMENT OUTLINE AND MARKET SHARE BY MODE OF ADMINISTRATION
6.2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET REVENUE BY MODE OF ADMINISTRATION, 2014 – 2025
6.3. Oral
6.3.1. Market growth indicators
6.3.2. Market revenue & growth rate, 2014 – 2025
6.4. Parenteral
6.4.1. Market growth indicators
6.4.2. Market revenue & growth rate, 2014 – 2025
6.5. Topical
6.5.1. Market growth indicators
6.5.2. Market revenue & growth rate, 2014 – 2025

CHAPTER 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET BY END-USER
7.1. SEGMENT OUTLINE AND MARKET SHARE BY END-USER
7.2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET REVENUE BY END-USER, 2014 – 2025
7.3. Veterinary Hospitals
7.3.1. Market growth indicators
7.3.2. Market revenue & consumption volume, 2014 – 2025
7.4. Veterinary Clinics
7.4.1. Market growth indicators
7.4.2. Market revenue & consumption volume, 2014 – 2025
7.5. Pharmacies
7.5.1. Market growth indicators
7.5.2. Market revenue & consumption volume, 2014 – 2025
7.6. Others
7.6.1. Market growth indicators
7.6.2. Market revenue & consumption volume, 2014 – 2025

CHAPTER 8. KEY VENDOR PROFILES
8.1. Cerner
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.2. Mckesson
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.3. Quest diagnostics
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.4. Athenahealth
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.5. Epic
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.6. Emc
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.7. Carecloud
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.8. Greenway
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.9. Allscripts
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.10. Qsi.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.11. Zoetis
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.12. Bayer HealthCare Pharmaceuticals LLC
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.13. Boehringer Ingelheim
8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.14. Merial
8.14.1. Company overview
8.14.2. Company snapshot
8.14.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.15. Eli Lilly and Company (Elanco Animal Health)
8.15.1. Company overview
8.15.2. Company snapshot
8.15.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.16. Meck
8.16.1. Company overview
8.16.2. Company snapshot
8.16.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market
8.17. Virbac
8.17.1. Company overview
8.17.2. Company snapshot
8.17.3. Business overview & Estimated Revenue from Veterinary Anti-infectives market

CHAPTER 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET BY REGIONS
9.1. SEGMENT OUTLINE AND MARKET SHARE BY REGIONS
9.2. GLOBAL VETERINARY ANTI-INFECTIVES MARKET PRODUCTION, CONSUMPTION & REVENUE BY REGION, 2014-2025
9.3. North America
9.3.1. Current trends
9.3.2. Market growth indicators
9.3.3. North America Veterinary Anti-infectives market revenue, production & Consumption, 2014-2025
9.3.3.1 U.S.
9.3.3.2 Canada
9.3.3.3 Mexico
9.4. Europe
9.4.1. Current trends
9.4.2. Market growth indicators
9.4.3. Europe Veterinary Anti-infectives market revenue, production & consumption, 2014-2025
9.4.3.1 UK
9.4.3.2 Germany
9.4.3.3 France
9.4.3.4 Italy
9.4.3.5 Rest of Europe
9.5. APAC
9.5.1. Current trends
9.5.2. Market growth indicators
9.5.3. APAC Veterinary Anti-infectives market revenue, production & consumption, 2014-2025
9.5.3.1 China
9.5.3.2 India
9.5.3.3 Japan
9.5.3.4 Rest of APAC
9.6. Rest of the world
9.6.1. Current trends
9.6.2. Market growth indicators
9.6.3. ROW Veterinary Anti-infectives market revenue, production & consumption, 2014-2025
9.6.3.1 Latin America
9.6.3.2 Middle East
9.6.3.3 Africa

• Cerner
• Mckesson
• Quest diagnostics
• Athenahealth
• Epic
• Emc
• Carecloud
• Greenway
• Allscripts
• Qsi.
• Zoetis
• Bayer HealthCare Pharmaceuticals LLC
• Boehringer Ingelheim
• Merial
• Eli Lilly and Company (Elanco Animal Health)
• Merck
• Virbac

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS

Esticast Logo

CORPORATE OFFICE

location  (US)

1055 West 7th Street, Los Angeles, CA 90017 (P) US

phone  +1-213-262-0704
location  (APAC Address)

Office No. 407, Navale Icon IT Park, Near Navale Bridge, Narhe, Pune, Maharashtra 411041

phone  +91-959-503-5024

COMPANY

SECURE ONLINE PAYMENTS

  • visa
  • mastercard
  • amex
  • discover

FOLLOW US

  • facebook
  • linkedin
  • phone
  • youtube
© 2022 | All Rights Reserved by Esticast Research & Consulting